#MinorSpliceosome
I am happy to share that I have received one of only four highly competitive DoW Prostate Cancer Idea Development Awards – New Investigator.
Cheers to my mentors, colleagues, and family. I could not have done this without you.
#ProstateCancerResearch #MinorSpliceosome #Augspachlab #Resilience
🎉 Welcome @ankeaugspach.bsky.social as new Assistant Professor at the Translational Cancer Research Program! Her lab studies the minor spliceosome to develop cancer therapies. Excited to have her at DBMR! #CancerResearch 👉 tinyurl.com/5t3p4hyn
@medfacultyunibe.bsky.social @unibe.ch
September 10, 2026 at 11:51 AM
Proud to share our new preprint on improving DNA-damaging cancer therapies through minor spliceosome inhibition. Treatments must be not only effective, but kinder. Grateful for the support. 🤍 www.biorxiv.org/content/10.6...
#minorspliceosome #breastcancer #prostatecancer #U6atac #RNAsplicing
December 14, 2025 at 6:25 PM
“If opportunity doesn’t knock, build a door.” – Milton Berle

@rahulkanadia.bsky.social ky.social, @marubin1.bsky.social and I have launched Verintas Therapeutics Inc.
to target the minor spliceosome in cancer.
Thanks to Nextwave X Partners-our 1st investor and believer.
#Verintas #minorspliceosome
August 17, 2025 at 5:32 PM
In cancer research, we chase the “untreatable” — but making current treatments more tolerable matters too. Grateful to the SwissLife Jubiläumsstiftung for supporting my work on minor spliceosome-based co-treatments to ease side effects and improve outcomes.
#swisslife #minorspliceosome #RNAbaseddrug
June 2, 2025 at 12:01 PM
October 1, 2025 at 8:27 AM